腹腔镜下乙醇硬化治疗子宫内膜异位囊肿的叙述性综述
该叙述性综述检索了PubMed、Embase、Web of Science、SCOPUS和Cochrane Library共271条记录,最终纳入4项单中心研究(1项随机对照试验、1项观察性研究、2项回顾性研究),评估腹腔镜下乙醇硬化治疗子宫内膜异位囊肿的有效性、安全性、卵巢储备及复发情况。结论认为该技术可行且安全,但现有数据有限且异质性大,需大规模多中心随机对照试验比较其与囊肿剥除或消融的疗效。
要点
- 腹腔镜乙醇硬化治疗子宫内膜异位囊肿可行且安全,但证据有限。
- 现有研究均为单中心,异质性大,需多中心随机对照试验验证。
- 未来试验应比较硬化治疗与囊肿剥除或消融,并考虑术后激素治疗。
核心结论
- 腹腔镜下乙醇硬化治疗子宫内膜异位囊肿似乎是可行且安全的替代方案,但现有数据有限且异质性大。
- 需要大规模多中心随机对照试验比较硬化治疗与囊肿剥除或消融,并考虑术后激素治疗,以明确其临床地位。
研究设计与样本
- 叙述性综述,检索PubMed、Embase、Web of Science、SCOPUS和Cochrane Library,最终纳入4项单中心研究:1项随机对照试验、1项观察性研究、2项回顾性研究。
主要发现
- 检索共获得271条记录,去除重复后筛选146篇标题和摘要,通过邮件提醒额外发现1项研究,8项研究进行全文评估,排除3项因研究设计错误和1项因研究人群重叠,最终纳入4项试验。
临床怎么用
- 腹腔镜乙醇硬化治疗可作为子宫内膜异位囊肿的一种可行且安全的替代选择,尤其适用于需要同时处理表浅和深部子宫内膜异位症或囊肿破裂的灵活情况。
局限性
- 现有数据有限且异质性大,纳入研究均为单中心,缺乏大规模多中心随机对照试验证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Endometriosis frequently involves the ovaries. Surgical management of endometriomas traditionally includes cystectomy, electrocoagulation, or ablative techniques. Ethanol sclerotherapy has emerged as a low-cost, time-efficient alternative. When performed laparoscopically, it allows simultaneous management of superficial and deep endometriosis and offers flexibility in cases of cyst rupture. This narrative review aims to summarize the current evidence regarding the use of laparoscopic ethanol sclerotherapy for endometriomas. DATA SOURCES: A comprehensive literature search was conducted in PubMed, Embase, Web of Science, SCOPUS and the Cochrane Library using three key concepts-endometriosis, laparoscopy, and sclerotherapy-combined with the Boolean operator "AND." Reference lists of included studies were screened to identify additional publications. METHODS OF STUDY SELECTION: Outcomes of interest included efficacy, safety, ovarian reserve, and recurrence after laparoscopic use of ethanol sclerotherapy. TABULATION, INTEGRATION AND RESULTS: The search yielded 271 records. After removal of duplicates, 146 titles and abstracts were screened. One additional study was identified by e-mail alert. Eight studies underwent full-text assessment. Three were excluded due to wrong study design and one due to overlap in study population. The four included trials consisted of one RCT, one observational study and two retrospective studies (all single-center). CONCLUSION: Laparoscopic ethanol sclerotherapy appears to be a feasible and safe alternative for the treatment of endometriomas. However, existing data are limited and heterogeneous. Large, multicenter randomized controlled trials comparing sclerotherapy with cystectomy or ablation, while accounting for postoperative hormonal therapy, are needed to define its role in clinical practice.
引用
- Geraerts A, Bafort C, Vanhie A, et al. Laparoscopic use of ethanol sclerotherapy in the treatment of endometriomas: a narrative review. J Minim Invasive Gynecol. 2026. PMID: 42595004. doi:10.1016/j.jmig.2026.06.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。